002004.SZ
华邦健康
SZSE · Basic Materials · C 制造业 · CN
CNY 4.47
−0.67%Year over year
Reported trailing growth
- Revenue
- -0.5%
- EBITDA
- —
- EBIT
- +1128.4%
- EPS
- +353.2%
- Free cash flow
- +121.9%
- Operating cash flow
- +46.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -4.5%
- EBITDA
- -4.8%
- EBIT
- -14.0%
- Net income
- +18.1%
- EPS
- +18.2%
- Free cash flow
- +4.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026